Dexcom Inc [DXCM] stock is trading at $59.72, up 0.18%. An important factor to consider is whether the stock is rising or falling in short-term value. The DXCM shares have gain 2.93% over the last week, with a monthly amount drifted -8.70%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer downgraded its rating to Perform on September 08, 2025. On August 21, 2025, Argus initiated with a Buy rating and assigned a price target of $100 on the stock. Truist started tracking the stock assigning a Buy rating and suggested a price target of $102 on June 16, 2025. Goldman initiated its recommendation with a Buy and recommended $104 as its price target on May 30, 2025. Mizuho started tracking with a Outperform rating for this stock on April 10, 2025, and assigned it a price target of $85. In a note dated February 03, 2025, Redburn Atlantic upgraded an Buy rating on this stock and boosted its target price from $85 to $115.
Dexcom Inc [DXCM] stock has fluctuated between $54.11 and $93.25 over the past year. Currently, Wall Street analysts expect the stock to reach $83.89 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $59.72 at the most recent close of the market. An investor can expect a potential return of 40.47% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
Dexcom Inc [NASDAQ:DXCM] reported sales of 4.52B for the trailing twelve months, which represents a growth of 21.64%. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.3 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 58.99 points at the first support level, and at 58.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 60.65, and for the 2nd resistance point, it is at 61.58.
Ratios To Look Out For
For context, Dexcom Inc’s Current Ratio is 1.56. On the other hand, the Quick Ratio is 1.38, and the Cash Ratio is 0.55. Considering the valuation of this stock, the price to sales ratio is 5.16, the price to book ratio is 8.54 and price to earnings (TTM) ratio is 33.24.
Transactions by insiders
Recent insider trading involved Heller Bridgette P, Director, that happened on Nov 12 ’25 when 1012.0 shares were sold. Director, Heller Bridgette P completed a deal on Nov 12 ’25 to buy 1012.0 shares. Meanwhile, President & COO Leach Jacob Steven bought 18200.0 shares on Nov 10 ’25.
